When may a physician legitimately offer enrollment in a randomized clinical trial (RCT) to her patient? Two answers to this question have had a profound impact on the research ethics literature. Equipoise, as originated by Charles Fried, which we term Fried\u27s equipoise (FE), stipulates that a physician may offer trial enrollment to her patient only when the physician is genuinely uncertain as to the preferred treatment. Clinical equipoise (CE), originated by Benjamin Freedman, requires that there exist a state of honest, professional disagreement in the community of expert practitioners as to the preferred treatment. FE and CE are widely understood as competing concepts. We argue that FE and CE offer separable and, in themselves, incompl...
The ethical tension in research design is often characterized as that between indi-vidual and collec...
Pragmatic clinical trials (PCTs) are considered a valuable means to directly improve day-to-day pati...
Abstract Background Early in the COVID-19 pandemic, the urgent need to discover effective therapies ...
When may a physician legitimately offer enrollment in a randomized clinical trial (RCT) to her patie...
It is commonly believed in research ethics that some form of equi-poise is a necessary condition for...
The equipoise requirement in clinical research demands that, if patients are to be randomly assigned...
Equipoise is defined by Freedman (1987: 141) as a “state of genuine uncertainty on the part of the c...
Equipoise is defined by Freedman (1987, p.141) as a "state of genuine uncertainty on the part of the...
Clinical equipoise has taken on the status of a sacred dogma of research ethics. It is refreshing to...
Equipoise is advocated as a means of achieving high scientific and ethical standards in randomised ...
This article is part of a series of papers examining ethical issues in cluster randomized trials (CR...
This article is part of a series of papers examining ethical issues in cluster randomized trials (CR...
Indiana University-Purdue University Indianapolis (IUPUI)Currently, the predominant view in research...
When a randomized controlled trial (RCT) that has potentially therapeutic benefits for research subj...
An apparent ethical dilemma arises when physicians consider enrolling their patients in randomized c...
The ethical tension in research design is often characterized as that between indi-vidual and collec...
Pragmatic clinical trials (PCTs) are considered a valuable means to directly improve day-to-day pati...
Abstract Background Early in the COVID-19 pandemic, the urgent need to discover effective therapies ...
When may a physician legitimately offer enrollment in a randomized clinical trial (RCT) to her patie...
It is commonly believed in research ethics that some form of equi-poise is a necessary condition for...
The equipoise requirement in clinical research demands that, if patients are to be randomly assigned...
Equipoise is defined by Freedman (1987: 141) as a “state of genuine uncertainty on the part of the c...
Equipoise is defined by Freedman (1987, p.141) as a "state of genuine uncertainty on the part of the...
Clinical equipoise has taken on the status of a sacred dogma of research ethics. It is refreshing to...
Equipoise is advocated as a means of achieving high scientific and ethical standards in randomised ...
This article is part of a series of papers examining ethical issues in cluster randomized trials (CR...
This article is part of a series of papers examining ethical issues in cluster randomized trials (CR...
Indiana University-Purdue University Indianapolis (IUPUI)Currently, the predominant view in research...
When a randomized controlled trial (RCT) that has potentially therapeutic benefits for research subj...
An apparent ethical dilemma arises when physicians consider enrolling their patients in randomized c...
The ethical tension in research design is often characterized as that between indi-vidual and collec...
Pragmatic clinical trials (PCTs) are considered a valuable means to directly improve day-to-day pati...
Abstract Background Early in the COVID-19 pandemic, the urgent need to discover effective therapies ...